Vaccine Protocols

Portada
Andrew P. Robinson, Martin P. Cranage, Michael J. Hudson
Springer Science & Business Media, 2008 M02 1 - 416 páginas
Vaccine research and development is advancing at an unprecedented pace, with an increasing emphasis on rational design based upon a fundamental und- standing of the underlying molecular mechanisms. The aim of this volume is to provide a selection of contemporary protocols that will be useful to both novice and advanced practitioner alike. The variety of procedures required to design, develop, produce, and assess a vaccine is immense and covers aspects of ch- istry, biochemistry, molecular biology, cell biology, and immunology. No single volume can hope to cover these topics exclusively. Rather, here we attempt to provide a methods sourcebook focusing on hands-on practical advice. Comp- mentary and background information may be found in other volumes in the Me- ods in Molecular Medicine series. Of particular interest are volumes on Dendritic Cell Protocols, Interleukin Protocols, Vaccine Adjuvants, and DNA Vaccines. Since the publication of the first edition of Vaccine Protocols there have been major advances, particularly in the areas of bacterial genomics, antig- specific T-cell quantification, genetic manipulation of vaccine vectors, the h- nessing of natural molecules concerned with the regulation of immune responses, and the burgeoning field of DNA vaccinology. Hence, the extensive revision of this edition with new chapters on live viral vaccine vectors, atte- ated bacterial vectors, immunomodulators, MHC-peptide tetrameric complexes, and the identification of vaccine candidates by genomic analysis. Additionally, chapters from the first edition have been updated to accommodate state-of-t- art methods in vaccinology.
 

Páginas seleccionadas

Contenido

1 Overview of Vaccines
1
2 TemperatureSensitive Mutant Vaccines
19
Construction of a ReplicationDeficient Recombinant Adenovirus
37
Vaccinia Virus
51
Semliki Forest Virus
69
6 Development of Attenuated Salmonella Strains That Express Heterologous Antigens
83
7 Expression and Delivery of Heterologous Antigens Using Lactic Acid Bacteria
101
8 Synthetic Peptides
115
Current Trends
223
15 Stimulation of Mucosal Immunity
245
16 Induction and Detection of TCell Responses
255
17 Construction of MHC Class IPeptide Tetrameric Complexes for Analysis of TCellMediated Immune Responses
279
18 Assessment of Functional Antibody Responses
289
19 The Use of Complete Genome Sequences in Vaccine Design
301
20 Severe Combined Immunodeficient SCID Mice in Vaccine Assessment
313
21 Clinical Trials
335

9 Genetic Detoxification of Bacterial Toxins
133
10 Preparation of PolysaccharideConjugate Vaccines
153
11 Adjuvant Formulations for Experimental Vaccines
175
12 Incorporation of Immunomodulators into Plasmid DNA Vaccines
195
13 Microencapsulation of Vaccine Antigens
211
Regulatory Expectations for Licensing and Batch Release
353
An Update
377
A Guide for the Researcher
391
Index
409
Derechos de autor

Otras ediciones - Ver todas

Términos y frases comunes

Información bibliográfica